SEC Comment Letter 0000000000-23-002452 to GH Research PLC (GHRS) (CIK 0001855129) (GHRS)
GH Research PLC (GHRS) (CIK 0001855129)
Date: March 14, 2023 · CIK: 0001855129 · Accession: 0000000000-23-002452
AI Filing Summary & Sentiment
File numbers found in text: 333-270418
Letter
United States securities and exchange commission logo March 14, 2023 Theis Terwey Chief Executive Officer GH Research PLC Joshua Dawson House Dawson Street Dublin 2 D02 RY95 Ireland Re:GH Research PLC Registration Statement on Form F-3 Filed March 9, 2023 File No. 333-270418 Dear Theis Terwey: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jason Drory at 202-551-8342 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Yasin Keshvargar
Show Raw Text
United States securities and exchange commission logo
March 14, 2023
Theis Terwey
Chief Executive Officer
GH Research PLC
Joshua Dawson House
Dawson Street
Dublin 2
D02 RY95
Ireland
Re:GH Research PLC
Registration Statement on Form F-3
Filed March 9, 2023
File No. 333-270418
Dear Theis Terwey:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jason Drory at 202-551-8342 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Yasin Keshvargar